ID Pharma Co., Ltd.

City:

Tokyo

Country:

Japan

Published Applications:

Last publication date:

2024-02-22

Patent Grants:

Last grant date:

2025-03-18

Top Inventors for applications by ID Pharma Co., Ltd.

These are the the leading inventors for applications assigned to ID Pharma Co., Ltd.:

Tsugumine SHU 3 Tokyo, Japan
Makoto INOUE 3 Tokyo, Japan
Hiroto HARA 2 Tokyo, Japan
Koji TANABE 2 Palo Alto, CA United States

Toyotaka MORI 2 Tokyo, Japan
Mamoru Hasegawa 1 Ibaraki, Japan
Tetsuro MATANO 1 Tokyo, Japan
Jitsutaro Kawaguchi 1 Chiyoda-ku, Tokyo, Japan

Jitsutaro KAWAGUCHI 1 Tokyo, Japan
Zhi-Dong Hu 1 Shanghai, China
Koichi SAEKI 1 Tokyo, Japan
Douglas B. Lowrie 1 Shanghai, China

Akira Kunitomi 1 San Francisco, CA United States
Kenta SUTO 1 Palo Alto, CA United States
Akihiro IIDA 1 Ibaraki, Japan
Kohji KUSANO 1 Tokyo, Japan

Hiroshi BAN 1 Ibaraki, Japan
Tsugumine Shu 1 Chiyoda-ku, Tokyo, Japan
Tsugumine Shu 1 Ibaraki, Japan
Xiao-Yong Fan 1 Shanghai, China

Recent patent applications by ID Pharma Co., Ltd.

ID Pharma Co., Ltd. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-02-22

US20240060051A1

Chemistry; metallurgy

Method for Producing Naive Human IPS Cells From Somatic Cells

#2 | 2022-06-02

US20220169990A1

Chemistry; metallurgy

METHOD FOR PRODUCING CARDIOMYOCYTE

#3 | 2020-12-17

US20200392455A1

Chemistry; metallurgy

NERVE CELL PRODUCTION METHOD

#4 | 2020-09-10 ✅ Patent 12,252,700 granted on 2025-03-18

US20200283797A1

Chemistry; metallurgy

Paramyxovirus vector

#5 | 2020-05-21 ✅ Patent 11,103,574 granted on 2021-08-31

US20200155669A1

Human necessities

Infectious disease vaccine using non-infectious paramyxovirus particle

#6 | 2018-03-29 ✅ Patent 10,828,359 granted on 2020-11-10

US20180085449A1

Human necessities

Anti-vaccine using sendai virus as vector

#7 | 2016-07-28 ✅ Patent 10,975,358 granted on 2021-04-13

US20160215270A1

Chemistry; metallurgy

Method for improving efficiency of inducing pluripotent stem cell

Also check out ID Pharma Co., Ltd.'s (Tokyo, Japan) applicant profile with 5 patent applications submitted.

AssigneeID:

162805 ⎘